Perfusable Three-Dimensional Polyurethane (PU) Scaffold Platform Promotes Multicellular Tumor Spheroid (MCTS) Formation of U87 Glioblastoma for Tumor Microenvironment Modeling
This study presents a biomimetic, perfusable three-dimensional polyurethane scaffold with brain-mimetic mechanical properties and interconnected pores that supports the long-term formation, viability, and drug-responsive growth of U87 glioblastoma multicellular tumor spheroids for advanced tumor microenvironment modeling and preclinical therapeutic screening.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Brain cancer is a formidable adversary, not just because of how aggressively it grows, but because of how it hides. The most common and deadly form, known as glioblastoma, thrives in a complex, three-dimensional world inside the brain. For decades, scientists have tried to study this disease in the lab using flat, two-dimensional cultures where cells are spread out like a single layer of paint on a plastic dish. While this method has taught us much about how cells divide, it fails to capture the true nature of the disease. In a living body, tumor cells do not sit in a flat line; they cluster together, push against one another, and interact with a surrounding environment that includes blood vessels and immune cells. This three-dimensional neighborhood, often called the tumor microenvironment, dictates how the cancer grows, how it resists treatment, and how it spreads. Without a way to model this complex structure, new drugs often look promising in the lab but fail when tested in patients, leaving researchers searching for a better way to see the disease as it truly exists.
To solve this, a team of researchers at the New York Institute of Technology and the University of Arkansas for Medical Sciences has developed a new tool designed to mimic the physical home of a brain tumor. They created a scaffold made of tiny, porous beads of a material called polyurethane. Imagine a sponge made of thousands of microscopic, interconnected balls, each with holes running through them. This structure is not just a container; it is a carefully engineered environment. The researchers found that the holes in their beads are about 250 micrometers wide, a size that allows cells to move in and out freely while ensuring that oxygen and nutrients can reach deep into the structure. More importantly, the material is soft and squishy, matching the stiffness of actual brain tissue. This is a crucial detail because brain cells are sensitive to how hard or soft their surroundings are; if the environment is too rigid, the cells behave differently than they would in a real human brain. By matching the texture and softness of the brain, the scaffold provides a realistic stage for the cancer to perform its natural behaviors.
The researchers tested this new platform using U87 glioblastoma cells, a standard type of brain cancer cell used in laboratories. They packed the porous beads into a dish and introduced the cells, watching to see how they would react over the course of a month. Within just two days, the cells began to stick to the beads and form small clusters. By the end of the first week, these clusters had grown into distinct, round balls of cells, known as multicellular tumor spheroids. These spheroids are significant because they naturally develop different zones, much like a real tumor, with active cells on the outside and dormant or dying cells in the center where nutrients are harder to reach. The scaffold supported this growth remarkably well. Even after four weeks, the cells remained healthy, with viability rates staying between 70 and 84 percent, depending on how many cells were started in the dish. This is a major improvement over traditional methods, where such structures often collapse or die off quickly because they cannot sustain their own weight or get enough food.
To ensure the platform was useful for testing new medicines, the team treated the growing spheroids with temozolomide, the standard drug used to treat glioblastoma. They observed that the drug worked, but not as aggressively as it might in a simple flat dish. After 24 hours, the number of living cells dropped to about 68 percent, and after 48 hours, it fell further to roughly 61 percent. This result was expected and actually valuable; it demonstrated that the scaffold creates a barrier that mimics the difficulty real tumors have in absorbing drugs. In a flat dish, drugs hit every cell instantly. In this three-dimensional scaffold, the drug has to work its way through layers of cells, just as it does in a human body. This slower, more realistic response suggests that the platform can help scientists predict how well a drug will actually work in a patient, potentially saving time and resources by filtering out treatments that might fail later in clinical trials.
The study concludes that this porous bead system offers a reliable, reproducible way to grow brain tumors in a lab that looks and feels more like the real thing. The researchers noted that the best results came when they started with a specific number of cells and let them grow for two weeks before testing, a condition that allowed the spheroids to mature without starving. While the current setup uses a single type of cell line, the design is flexible enough to eventually include other cell types, such as immune cells or blood vessel builders, to create an even more complete model of the tumor's neighborhood. The ultimate goal is to integrate these beads into larger machines that can pump fresh nutrients through them, simulating blood flow and allowing for even longer, more accurate studies. By providing a stable, soft, and porous home for cancer cells, this new scaffold helps scientists move beyond flat, unrealistic models and toward a deeper understanding of how glioblastoma truly survives and resists treatment.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.